Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024.

Revenue
+4.97%
EPS
+731.9%
Free cash flow
+255.6%
Total debt
−9.48%

Quarter to September 2026, against a year earlier

25.48 0.17 −0.66%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
21.3×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
4.91 50.89 21.65 41.40 37.15 33.53 0.00 7.41 0.00 0.00
Piotroski F-Score
6 7 8 5 5 4 3 6 4 4
P/S ratio
2.39 3.45 3.17 3.75 3.50 3.55 2.56 1.90 1.40 0.87
Altman Z-Score
4.39 5.00 5.31 4.92 4.47 2.43 1.55 1.97 1.81 2.12
Altman Z″-Score (non-manufacturers)
6.11 6.17 6.17 5.82 5.68 3.23 1.98 3.19 2.88 3.86
P/FCF ratio
25.95 33.22 25.88 30.23 35.24 28.15 30.84 15.19 25.95 29.53
Beneish M-Score
(1.27) (2.73) (2.59) (2.74) (2.56) (2.23) (3.32) (2.94) (2.76) (2.67)
P/Operating CF
34.03 93.28 49.57 51.34 57.36 62.18 58.60 37.02 30.47 16.79
Dividend Safety Score
— — — — — — — — — 0
P/B ratio
2.93 4.00 4.47 5.38 4.68 4.72 4.36 2.32 2.12 1.61
EV/Sales
2.39 3.46 3.32 3.92 3.71 4.76 4.04 2.93 2.47 1.54
EV/EBITDA
15.69 17.95 15.62 17.20 17.63 26.07 29.39 17.94 17.65 11.96
EV/FCF
25.93 33.33 27.09 31.66 37.36 37.75 48.73 23.44 45.78 52.15
Current Ratio
2.40 2.57 2.12 2.32 2.52 2.09 1.69 1.48 1.36 2.31
Net Debt/EBITDA
(0.01) 0.06 0.70 0.78 1.00 6.63 10.79 6.31 7.65 5.19
Debt/Equity
0.34 0.39 0.44 0.68 0.71 1.94 2.82 1.62 1.87 1.55
ROE
57.92% 6.92% 18.21% 12.69% 13.25% 14.39% (32.41%) 36.98% (8.38%) (14.58%)
ROA
27.20% 3.69% 9.42% 5.90% 5.77% 4.80% (7.87%) 9.39% (2.40%) (4.18%)
ROIC
5.64% 8.72% 10.41% 11.16% 9.03% 3.54% (8.54%) 2.31% 0.05% (1.41%)
Return on Tangible Assets
61.15% 6.67% 20.14% 11.39% 11.24% 13.08% (30.56%) 44.50% (12.45%) (14.05%)
Average Days of Receivables
60.73 61.83 60.51 60.91 62.76 79.00 93.31 60.56 57.62 60.41
Earnings Yield
20.39% 1.97% 4.62% 2.42% 2.69% 2.98% (9.46%) 13.49% (4.39%) (9.68%)
Free Cash Flow Yield
3.85% 3.01% 3.86% 3.31% 2.84% 3.55% 3.24% 6.58% 3.85% 3.39%
Free Cash Flow per Share
1.71 2.02 2.54 2.77 2.28 3.05 1.65 2.56 1.12 0.65
Book value per Share
15.16 16.79 14.73 15.54 17.14 18.17 11.70 16.74 13.77 11.89
Free Cash Flow
935.00 1,098.00 1,358.00 1,408.00 1,159.00 1,531.00 834.00 1,294.00 573.00 332.00
EV/EBIT
32.54 28.41 23.23 25.16 26.80 42.82 0.00 42.91 1,873.83 0.00
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026